Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Svea Vaccin AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 135,496 More Arrow 203,397 Less Arrow 160,003
Financial expenses 114 Less Arrow 57 Less Arrow 0
Earnings before taxes -25,685 More Arrow 16,772 More Arrow 17,736
EBITDA -24,620 More Arrow 17,008 More Arrow 17,058
Total assets 23,572 More Arrow 46,830 Less Arrow 35,247
Current assets 16,706 More Arrow 43,393 Less Arrow 32,132
Current liabilities 19,036 More Arrow 27,274 Less Arrow 19,640
Equity capital 4,537 More Arrow 17,774 Less Arrow 14,670
- share capital 103 Less Arrow 101 Less Arrow 95
Employees (average) 94 Less Arrow 91 Less Arrow 65

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 19.2% More Arrow 38.0% More Arrow 41.6%
Turnover per employee 1,441 More Arrow 2,235 More Arrow 2,462
Profit as a percentage of turnover -19.0% More Arrow 8.2% More Arrow 11.1%
Return on assets (ROA) -108.5% More Arrow 35.9% More Arrow 50.3%
Current ratio 87.8% More Arrow 159.1% More Arrow 163.6%
Return on equity (ROE) -566.1% More Arrow 94.4% More Arrow 120.9%
Change turnover -71,568 More Arrow 32,040 Less Arrow -61,216
Change turnover % -35% More Arrow 19% Less Arrow -28%
Chg. No. of employees 3 More Arrow 26 Less Arrow -15
Chg. No. of employees % 3% More Arrow 40% Less Arrow -19%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.